Evidence map›Paper›PMID 41992032›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

Functional genomic profiling of schizophrenia-associated genes reveals key microglial regulators.

Joy E Horng, Liam T McCrea, Rebecca E Batorsky, Joshua J Bowen, Camilla Boschian, Yoonjae Song, Roy H Perlis, Steven D Sheridan

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Joy E Horng *Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Liam T McCrea *Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Rebecca E Batorsky *Tufts Institute for Artificial Intelligence, Tufts University, Medford, MA, USA.
Joshua J BowenCenter for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Camilla BoschianCenter for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Yoonjae SongCenter for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Roy H PerlisCenter for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. rperlis@mgh.harvard.edu.ORCID http://orcid.org/0000-0002-5862-6757
Steven D SheridanCenter for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. ssheridan2@mgh.harvard.edu.ORCID http://orcid.org/0000-0003-1045-1158

Funding

Patient-derived Models of Synaptic Pruning in SchizophreniaR01MH120227 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI PERLIS, ROY H. · 2019 to 2023
$3.1M
Characterization of schizophrenia liability genes in models of human microglial synaptic pruningR01MH131687 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI ROY H. Perlis, Steven D Sheridan · 2023 to 2026
$2.4M
NIMH NIH HHS R01 MH120227NIMH NIH HHS R01 MH131687U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH120227U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH131687
6 · The paper itself

Abstract

Microglia are increasingly recognized as key regulators of neural circuit development and putative contributors to the pathophysiology of neuropsychiatric disorders such as schizophrenia (SCZ). However, the functional impact of SCZ-associated genes in microglia remains largely unexplored. Here, we performed an arrayed CRISPR targeting screen of 30 SCZ-associated genes predicted to be differentially expressed in human microglia-like cells. Target genes were prioritized based on post-mortem transcriptomic relevance and predicted ontology-based roles in phagocytosis pathways. We quantified phagocytic activity and morphological changes following gene targeting using high-content confocal imaging. Key targets, including CYFIP1, MSR1, TREM2, SYK, ITGB2, ITGAM, and IRF8, modulated phagocytosis and altered morphological properties consistent with activation states, validating their functional roles in microglia. To elucidate transcriptional impact, we further applied a multiplexed RNA sequencing platform across gene targets. These analyses revealed gene-specific transcriptional signatures, implicating divergent pathways related to phagocytic, activation, cytoskeletal, and lysosomal function. Together, these findings demonstrate the utility of CRISPR-based functional genomics in characterizing microglia function and identifying new target genes and mechanisms that may underlie their contributions to SCZ pathophysiology.

Indexed as

MicrogliaSchizophreniaGene Expression ProfilingGenomicsHumansPhagocytosis

Identifiers

PMID41992032
PMCPMC13389400

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.